Decreased clearance of diflunisal in renal insufficiency—an alternative explanation [letter]
- 1 August 1980
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 10 (2) , 185-186
- https://doi.org/10.1111/j.1365-2125.1980.tb01744.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Decreased body clearance of diflunisal in renal insufficiency‐an alternative explanation [letter]British Journal of Clinical Pharmacology, 1979
- MEASUREMENT OF CLOFIBRIC ACID (CPIB) METABOLITES IN PLASMA OF PATIENTS ON CLOFIBRATE THERAPYClinical and Experimental Pharmacology and Physiology, 1979
- Plasma half-life of clofibric acid in renal failure.Published by Wiley ,1979
- Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.British Journal of Clinical Pharmacology, 1979
- OXAZEPAM DISPOSITION IN UREMIC PATIENTS1977
- BIOTRANSFORMATION AND EXCRETION OF LORAZEPAM IN PATIENTS WITH CHRONIC RENAL FAILUREBritish Journal of Clinical Pharmacology, 1976
- Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.1975
- Restrictions Imposed on Antibiotic Therapy by Renal FailureArchives of internal medicine (1960), 1959
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. III. PENICILLIN, STREPTOMYCIN, ERYTHROMYCIN AND KANAMYCIN*†Journal of Clinical Investigation, 1959